<code id='C08F5BDD81'></code><style id='C08F5BDD81'></style>
    • <acronym id='C08F5BDD81'></acronym>
      <center id='C08F5BDD81'><center id='C08F5BDD81'><tfoot id='C08F5BDD81'></tfoot></center><abbr id='C08F5BDD81'><dir id='C08F5BDD81'><tfoot id='C08F5BDD81'></tfoot><noframes id='C08F5BDD81'>

    • <optgroup id='C08F5BDD81'><strike id='C08F5BDD81'><sup id='C08F5BDD81'></sup></strike><code id='C08F5BDD81'></code></optgroup>
        1. <b id='C08F5BDD81'><label id='C08F5BDD81'><select id='C08F5BDD81'><dt id='C08F5BDD81'><span id='C08F5BDD81'></span></dt></select></label></b><u id='C08F5BDD81'></u>
          <i id='C08F5BDD81'><strike id='C08F5BDD81'><tt id='C08F5BDD81'><pre id='C08F5BDD81'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:2751
          Humana sign -- health business coverage from STAT
          Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

          Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

          The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

          advertisement

          The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Bill would stop addiction treatment from triggering child abuse inquiry
          Bill would stop addiction treatment from triggering child abuse inquiry

          WORCESTER,MA-6/7/2023KaylaFordhugsher2-year-oldson,Memphis,intheiryardinWorcester,MA.ErinClark/Globe

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          FDA panel signals lack of confidence in Amgen cancer drug data

          AdobeTheclearanceofafirst-of-its-kindcancertreatmentmadebyAmgenisonshakiergroundfollowingaFoodandDru